Key facts
- Heidi’s last known valuation is $703.0M (Nov 2025).
- It has raised $129.6M; the latest was Later Stage VC ($98.0M) in Nov 2025.
- Notable investors include Alumni Ventures, Goodwater Capital, Menlo Ventures, Headline, Phoenix Court — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Heidi
- ·The full record, as it builds
Funding rounds
No funding rounds for Heidi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heidi
Developer of a clinical training and decision support tool designed to practice clinical reasoning. The company's tool provides real-time data collection for patient feedback and patients' diseases for diagnosis and facilitates the storage of collected data automatically, which can be viewed on the built-in dashboard, enabling medical professionals to learn and analyze patients' health to eliminate missed diagnoses.
- Sector
- Healthcare
- HQ
- Melbourne, NY, Australia
- Founded
- 2019
- Employees
- 200
- Website
- heidihealth.com/
- Ownership
- Privately Held (backing)
Heidi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heidi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heidi in its N-PORT filings yet. We sweep new filings monthly.